Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4221.00 | 3855.25 | 1.0949 | 1.1313 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3244.00 | 3855.25 | 0.8415 | 0.7719 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 2952.00 | 3855.25 | 0.7657 | 0.6585 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 2500.00 | 1434.95 | 4066.00 | 3855.25 | 1.0547 | 1.0761 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4090.00 | 3855.25 | 1.0609 | 1.0847 | |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 2500.00 | 1434.95 | 3732.00 | 3855.25 | 0.9680 | 0.9549 |
| BT-20 | Linsitinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3843.00 | 3855.25 | 0.9968 | 0.9955 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3683.00 | 3855.25 | 0.9553 | 0.9369 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 3559.00 | 3855.25 | 0.9232 | 0.8909 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2011.00 | 3855.25 | 0.5216 | 0.2671 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3716.00 | 3855.25 | 0.9639 | 0.9491 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3885.00 | 3855.25 | 1.0077 | 1.0108 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 3949.00 | 3855.25 | 1.0243 | 1.0340 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3902.00 | 3855.25 | 1.0121 | 1.0170 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3897.00 | 3855.25 | 1.0108 | 1.0152 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4110.00 | 3855.25 | 1.0661 | 1.0918 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 3967.00 | 3855.25 | 1.0290 | 1.0405 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4089.00 | 3855.25 | 1.0606 | 1.0843 | |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4179.00 | 3855.25 | 1.0840 | 1.1164 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1393.00 | 3855.25 | 0.3613 | -0.0206 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4142.00 | 3855.25 | 1.0744 | 1.1032 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 3905.00 | 3855.25 | 1.0129 | 1.0181 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1244.00 | 3855.25 | 0.3227 | -0.0953 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 3756.00 | 3855.25 | 0.9743 | 0.9638 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4112.00 | 3855.25 | 1.0666 | 1.0925 |